PANAGORA ASSET MANAGEMENT INC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$8,387,000
+130.9%
48,531
+53.5%
0.04%
+126.3%
Q4 2014$3,633,000
+4.2%
31,611
+41.7%
0.02%
+11.8%
Q3 2014$3,485,000
-59.4%
22,306
-68.0%
0.02%
-59.5%
Q2 2014$8,593,000
-19.4%
69,666
-32.3%
0.04%
-16.0%
Q1 2014$10,658,000
+172.4%
102,866
+136.4%
0.05%
+177.8%
Q4 2013$3,913,000
+314.1%
43,508
+208.0%
0.02%
+260.0%
Q3 2013$945,000
+1.1%
14,1280.0%0.01%0.0%
Q2 2013$935,00014,1280.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Verition Fund Management LLC 2,787,800$481,760,00055.98%
Brenner West Capital Advisors 1,800,000$311,058,00028.01%
FNY Managed Accounts LLC 180,357$31,167,493,00025.70%
Twin Securities, Inc. 1,189,192$205,505,00024.16%
FIRST NEW YORK SECURITIES LLC /NY 98,099$16,952,488,00016.70%
HARVEST MANAGEMENT LLC 77,500$13,393,00014.40%
Tyrus Capital S.A.M. 687,800$118,859,00013.24%
BARDIN HILL MANAGEMENT PARTNERS LP 472,550$81,661,00011.65%
ARGENTIERE CAPITAL AG 151,500$26,181,00010.81%
Sachem Head Capital 725,000$125,425,0008.31%
View complete list of SALIX PHARMACEUTICALS INC shareholders